27 communication-engineering-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"RIKEN" Fellowship positions at City of Hope
Sort by
Refine Your Search
-
strategies. Through these efforts, we aim to accelerate the translation of molecular and clinical insights into tools that improve patient outcomes. More information about the lab can be found here: https
-
that improve precision oncology and patient outcomes. More information about the lab can be found here: https://www.nathlab.org As a successful candidate, you will: Develop AI/ML models to
-
software (Word, PowerPoint, Excel, databases) and basic statistical principles Additional Information: · For more information on nPOD please visit here : https://npod.org/ · For
-
our ReCord Study ( https://record.umn.edu ). Qualifications Your qualifications should include: · Ph.D. degree in genetics, genetic epidemiology, biological sciences, or a related discipline is
-
genomics, molecular biology, cell biology, immunology, and in vivo model systems. For more information about Dr. Zhaohui Gu’s lab, please visit: https://gu-lab.net and https://www.cityofhope.org
-
. Expertise in using mouse models to study metabolic diseases is preferred. For a complete list of Publications please visit here: https://www.ncbi.nlm.nih.gov/myncbi/1J54E41I5YVku/bibliography
-
research integrates fundamental immunology, functional genomics, and translational cell engineering to uncover mechanisms of immune regulation and translate these discoveries into next-generation
-
opportunities. Prior experience with tissue culture, animal models, high-parameter flow cytometry, spatial transcriptomics or proteomics, and cell gene engineering techniques is desired, but not required. This
-
-herpesviruses, particularly Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), and rhesus lymphocryptovirus (rhLCV). Our work integrates molecular virology, vaccine engineering
-
tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer immunotherapies targeting metastatic cancer cells. Cancer immunotherapy is